1. Home
  2. DV vs DNTH Comparison

DV vs DNTH Comparison

Compare DV & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DoubleVerify Holdings Inc.

DV

DoubleVerify Holdings Inc.

HOLD

Current Price

$10.99

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$42.19

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DV
DNTH
Founded
2008
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.9B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DV
DNTH
Price
$10.99
$42.19
Analyst Decision
Buy
Strong Buy
Analyst Count
17
10
Target Price
$16.56
$68.00
AVG Volume (30 Days)
2.3M
756.3K
Earning Date
11-07-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$733,324,000.00
$3,078,000.00
Revenue This Year
$17.93
N/A
Revenue Next Year
$10.74
N/A
P/E Ratio
$41.60
N/A
Revenue Growth
14.86
N/A
52 Week Low
$7.64
$13.37
52 Week High
$23.11
$45.46

Technical Indicators

Market Signals
Indicator
DV
DNTH
Relative Strength Index (RSI) 52.62 54.91
Support Level $10.83 $42.70
Resistance Level $11.26 $44.06
Average True Range (ATR) 0.27 1.74
MACD 0.10 -0.39
Stochastic Oscillator 73.85 28.78

Price Performance

Historical Comparison
DV
DNTH

About DV DoubleVerify Holdings Inc.

DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

Share on Social Networks: